Form 4 for LLY Lilly (Eli)
Accepted 2024-02-14 00:00:00 ET · period of report 2024-02-12 · accession 0000059478-24-000036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-14 | 2024-02-12 | LLY | Norton Johna | EVP, Gbl Quality | A - Grant | $737.26 | +1,668 | 32.5K | +5% | +$1.23M |
| D | 2024-02-14 | 2024-02-12 | LLY | Norton Johna | EVP, Gbl Quality | A - Grant | $0.00 | +1,308 | 1,308 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-12 | A | A | 1,668 | $737.26 | 32,484 | D | — | — | |
| 2 | Derivative | Restricted Stock Unit | 2024-02-12 | A | A | 1,308 | $0.00 | 1,308 | D | — · 2025-02-01 to 2025-02-01 | 1,308 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |